INmune Bio, Inc. (INMB)
$2.36+1.72%Close
BUYRECOVERY · day 18
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $63M
- Avg volume
- 629.2K
- Beta
- 0.90
- P/E (TTM)
- -3.42
- Short % float
- 9.96%
- Days to cover
- 6.6
- SI change
- -7.6%
- 1W
- +10.80%
- 1M
- +45.68%
- 3M
- +62.76%
- YTD
- +53.25%
- vs SPY 1W
- +11.99%
- vs SPY 1M
- +42.36%
- vs SPY 3M
- +60.37%
- vs SPY YTD
- +41.49%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CAHSELLCardinal Health, Inc.BEARQ 12$232.37+1.25%
- BCDABUYBioCardia, Inc.RECOVERYQ -3$1.06+4.95%
- MTNBSELLMatinas BioPharma Holdings, Inc.CRISISQ -5$0.20+0.00%
- GNTASELLGenenta Science S.p.A.CRISISQ -8$1.15-8.73%
- MREOSELLMereo BioPharma Group plcCRISISQ -5$0.29+0.00%
- BDXBUYBecton, Dickinson and CompanyBULLQ 18$190.74-0.66%
- ICUIBUYICU Medical, Inc.BULLQ 22$182.55-0.16%
- NIVFSELLNewGenIvf Group LimitedCRISISQ -32$0.49-15.52%
- ONCOSELLOnconetix, Inc.CRISISQ 6$0.66+1.54%
- ANIXBUYAnixa Biosciences, Inc.RECOVERYQ 6$3.62-2.43%
- ANROBUYAlto Neuroscience, Inc.BULLQ 27$36.25+5.75%
- CRBPBUYCorbus Pharmaceuticals Holdings, Inc.RECOVERYQ 6$10.69+2.99%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
